Testing Adaptive Therapy Protocols using Gemcitabine and Capecitabine on a Mouse Model of Endocrine-Resistant Breast Cancer
S. SEYEDI, R. Teo, L. Foster, D. Saha, L. Mina, D. Northfelt, K. S. Anderson, D. Shibata, R. Gatenby, L. Cisneros, B. Troan, A. R. A. Anderson, C. C. Maley
This study tests adaptive therapy protocols using gemcitabine and capecitabine on a mouse model of endocrine-resistant breast cancer, finding improved survival with adaptive strategies over high-dose combination therapy.
bioRxiv · Sep 18, 2023 · PreprintCancer Biology